Bethany Sensenig
CIK 1899935 · Chief Financial Officer · last filed 2026-06-11
Bethany Sensenig is a Chief Financial Officer who has filed 17 SEC Form 4 insider transactions across 4 companies since 2022. The most recent filing, for KALV, was dated Jun 11, 2026. Across all open-market trades the lifetime net is −$466.1K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $48.8K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$48.8K
4
17
-$466.1K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KalVista Pharmaceuticals, Inc. (KALV) Delisted | Director | — | $27.00 | — | $0 | 2 | 2026-06-11 |
| ACOG | Director | 5,489 | $8.88 | $48.8K | $0 | 1 | 2026-04-17 |
| SUPN | Director | 0 | $46.88 | $0 | -$455.1K | 7 | 2026-02-23 |
| 9 METERS BIOPHARMA, INC. (NMTR) Delisted | Chief Financial Officer | 41,077 | $0.07 | $3.0K | -$11.0K | 3 | 2023-04-21 |
Recent Filings
17 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-11 | KalVista Pharmaceuticals, Inc. (KALV) Delisted | Disp (D) | — | $0 | EDGAR |
| 2026-04-17 | ACOG | Grant (A) | +5,489 | $0 | EDGAR |
| 2026-02-23 | SUPN | Mixed | — | -$228.3K | EDGAR |
| 2026-02-20 | SUPN | Grant (A) | — | $0 | EDGAR |
| 2026-02-19 | SUPN | Notice (144) | −4,475 | -$224.6K | EDGAR |
| 2025-10-02 | KalVista Pharmaceuticals, Inc. (KALV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-08-18 | SUPN | Sell (S) | −5,369 | -$226.8K | EDGAR |
| 2025-08-14 | SUPN | Notice (144) | −5,369 | -$228.9K | EDGAR |
| 2025-02-24 | SUPN | Mixed | +5,369 | $0 | EDGAR |
| 2025-02-21 | SUPN | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.